Literature DB >> 6498754

The impact of pain on the patient with cancer.

C S Cleeland.   

Abstract

Pain is one of the most feared consequences of cancer. Until recently, however, little has been known about its prevalence, severity, and impact on the patient with cancer. The presence of pain, despite efforts to treat it, represents a continued source of frustration for patients, their families, and the health care team. Although often one of the early indicators of the presence of disease, pain is not a significant problem for the majority of patients in the early stages of disease, with 5% to 10% of patients with solid tumors reporting pain at a level that interferes with mood and activity. But when metastatic disease is present, about one in three patients reports significant pain, and our data and those of others indicate that the majority of patients with end-stage disease will report pain of a severity that interferes with several aspects of the patient's quality of life. Site of tumor is also significantly related to the progression of pain. The relationship between pain intensity and depression and anxiety is examined in detail, and the treatment implications of this relationship discussed. Whereas a modest relationship between pain intensity and depression has been found across several studies, the possibility that depression is a causative factor in the pain experienced by the cancer patient may have been overemphasized. Data on the relief of pain in cancer are reported from the perspective of patients as well as the physicians and nurses who treat them. The majority of physicians and nurses specializing in cancer treatment whom we have surveyed believe that cancer patients in general are undermedicated for pain. Patient survey data indicate that only 50% of cancer patients with pain report 70% or greater pain relief with analgesic medication. Although a number of nonsystemic treatments may be useful for cancer pain management (such as nerve blocks, neurosurgery, and behavioral treatments), they are not widely available and there are few controlled studies of their effectiveness. Teaching patients to report the level of their pain on simple pain intensity scales has proven useful in monitoring the effectiveness of pain management, as well as in helping establish pain control goals for the individual patient.

Entities:  

Mesh:

Year:  1984        PMID: 6498754     DOI: 10.1002/1097-0142(19841201)54:2+<2635::aid-cncr2820541407>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Effectiveness of a clinical intervention to eliminate barriers to pain and fatigue management in oncology.

Authors:  Tami Borneman; Marianna Koczywas; Virginia Sun; Barbara F Piper; Cynthia Smith-Idell; Benjamin Laroya; Gwen Uman; Betty Ferrell
Journal:  J Palliat Med       Date:  2011-01-27       Impact factor: 2.947

2.  Improvement of recovery parameters using patient-controlled epidural analgesia after oncological surgery. A prospective, randomized single center study.

Authors:  Armeana Olimpia Zgâia; Cosmin Ioan Lisencu; Alexandru Rogobete; Cătălin Vlad; Patriciu Achimaş-Cadariu; Gabriel Lazăr; Maximilian Muntean; Florin Ignat; Vlad Ormindean; Alexandru Irimie
Journal:  Rom J Anaesth Intensive Care       Date:  2017-04

3.  A study of the needs of cancer patients and their relatives.

Authors:  B Herity; N Hilliard; M Moriarty; J Fennelly; R Conroy; M Casey
Journal:  Ir J Med Sci       Date:  1987-06       Impact factor: 1.568

4.  A practical approach to improving pain control in cancer patients.

Authors:  M L Brigden; J B Barnett
Journal:  West J Med       Date:  1987-05

5.  Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life.

Authors:  Edward Chow; Keyue Ding; Wendy R Parulekar; Rebecca K S Wong; Yvette M van der Linden; Daniel Roos; William F Hartsell; Peter Hoskin; Jackson S Y Wu; Abdenour Nabid; Francisca Ong; Geertjan van Tienhoven; Scott Babington; William F Demas; Carolyn F Wilson; Michael Brundage; Liting Zhu; Ralph M Meyer
Journal:  Support Care Cancer       Date:  2015-09-23       Impact factor: 3.603

Review 6.  Cancer pain and depression: a systematic review of age-related patterns.

Authors:  Lucia Gagliese; Lynn R Gauthier; Gary Rodin
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

7.  Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.

Authors:  Rachel McDonald; Keyue Ding; Edward Chow; Ralph M Meyer; Abdenour Nabid; Pierre Chabot; Genevieve Coulombe; Shahida Ahmed; Joda Kuk; Rashid Dar; Aamer Mahmud; Alysa Fairchild; Carolyn F Wilson; Jackson S Y Wu; Kristopher Dennis; Carlo DeAngelis; Rebecca K S Wong; Liting Zhu; Michael Brundage
Journal:  Support Care Cancer       Date:  2016-07-27       Impact factor: 3.603

Review 8.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 9.  Psychosocial aspects of cancer pain.

Authors:  F Stiefel
Journal:  Support Care Cancer       Date:  1993-05       Impact factor: 3.603

10.  [Intractable cancer pain as a reason for referral : Analysis of pain etiology and previous drug treatment.].

Authors:  S Grond; D Zech; H Dahlmann; S A Schug; B Stobbe; K A Lehmann
Journal:  Schmerz       Date:  1990-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.